Celligenics Announces China Market Entry, & Signs MOU With West China Hospital
Updated: Sep 21, 2021
Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee Meeting.
We are also pleased to announce that we have selected Chengdu as our headquarters in China, and will be developing an Advanced Therapeutics Development Centre in Chengdu’s High-Tech Industrial Development Zone.
We would like to thank Enterprise (ESG) for their support in our endeavour to build a resilient and competitive global company.
Read More Here: https://www.enterprisesg.gov.sg/media-centre/media-releases/2021/september/mr06621_singapore-and-sichuan-deepen-collaboration-in-trade-and-connectivity-and-innovation